|
Interrogating immune signatures in the thoracic duct of patients with multiple sclerosis |
1F31AI167501-01 |
|
NIAID |
2022 |
|
Prosthetic Joint Infection After Primary Total Knee Arthroplasty: Incidence, Microbiology and Risk Factors |
1F32AI164809-01A1 |
|
NIAID |
2022 |
|
Investigation of enterovirus D68 pathogenesis in the human spinal cord |
1K08AI171177-01 |
|
NIAID |
2022 |
|
Mechanistic and functional dissection of inflammaging in Down syndrome |
1R01AI166835-01A1 |
|
NIAID |
2022 |
|
Role of Natural Killer Cell Diversity in Multiple Sclerosis Risk and Disease Course |
1R01AI169070-01A1 |
|
NIAID |
2022 |
|
Long non-coding RNA signatures to distinguish relapsing-remitting multiple sclerosis from primary progressive and secondary progressive multiple sclerosis |
1R43AI157674-01A1 |
|
NIAID |
2022 |
|
Developing botanical-derived chemical tools for controlling mosquito vectors |
1R56AI158674-01A1 |
|
NIAID |
2022 |
|
Targeted in vivo perturbation for dissecting tissue immune responses |
2U19AI128949-06 |
|
NIAID |
2022 |
|
Clinical Core |
2U19AI128949-06 |
|
NIAID |
2022 |
|
Mechanistic dissection of the link between virus infection and Alzheimer’s disease in a model organism |
3R01AI137471-05S1 |
|
NIAID |
2022 |